Genetix drug success prompts $35M funding, exec shakeup, hiring plans Mass High Tech:
The Journal of New England Technology
Fri, 12 Mar 2010 05:50 AM PST
Genetix Pharmaceuticals Inc. has raised a venture round of $35 million dollars following the release of data showing that its drug target for a rare disease calledAdrenoleukodystrophy has halted the ailment in all three human cases.
Read More here...